A UK Multicentre, Health-Related Quality of Life Study for Children and Adolescents With XLH

CompletedOBSERVATIONAL
Enrollment

32

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

July 29, 2022

Study Completion Date

July 29, 2022

Conditions
X-Linked Hypophosphataemia
Trial Locations (6)

EH9 1LF

Royal Hospital for Sick Children, Edinburgh

G12 0XH

NHS Greater Glasgow & Clyde- South Glasgow University Hosp Division, Glasgow

LS9 7TF

Leeds Teaching Hospitals NHS Trust, Trust Headquarters, St. James's University Hospital, Leeds

SE1 7EH

Evelina Childrens Hospital, London

M13 9WL

Royal Manchester Children's Hospital, Manchester

S10 2RX

Sheffield Childrens Hospital, Sheffield

All Listed Sponsors
lead

Kyowa Kirin Pharmaceutical Development Ltd

INDUSTRY

NCT04819490 - A UK Multicentre, Health-Related Quality of Life Study for Children and Adolescents With XLH | Biotech Hunter | Biotech Hunter